Newsfeeds Archive - Page 29 of 56

2 minute read

Are Psychedelics A Threat To Alcohol And Tobacco Industries? A Glance At Thriving Advances

April 4, 2:42 PM

As the attachment to both tobacco and alcohol is deeply rooted and likely intertwined with other human and societal factors, it is evident these behaviors are complex to analyze. And yet, the near future seems to hold hope for those ready and willing to disengage from these practices. The formula would include patience, support and psychedelics.

NFLX

2 minute read

DMT For Major Depression Shows Remarkable Benefits After Six-Month Trial

By Lara Goldstein

April 4, 2:31 PM

Short-acting psychedelics company Small Pharma Inc.

DMTTF

2 minute read

Intravenous DMT Therapy Seeks Ideal Dosage For Stroke And TBI Treatment

By Lara Goldstein

April 4, 2:25 PM

Canadian biopharma company Algernon Pharmaceuticals Inc.

AGNPF

2 minute read

Mydecine: 2022 Financials & Business Update By Next-Gen Psychedelics Producer, Smoke Cessation Trial And More

By Lara Goldstein

April 3, 5:12 PM

Colorado and Leiden-based biotech company Mydecine Innovations Group (OTC: MYCOF) has shared its financial results and business highlights for the period ended December 31, 2022. In ciphers:

MYCOF

1 minute read

MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update

By Lara Goldstein

April 3, 3:46 PM

Specialty drug delivery technology biopharma company Revive Therapeutics Ltd. (OTCQB: RVVTF) is undertaking research and development activities for its proprietary transdermal microneedle patch to deliver MDMA toward IND-enabling studies, supported by an exclusive supply deal with PharmaAla Biotech Holdings Inc.

PHRRF